Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/60045
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Dogan, Cihangir | - |
dc.contributor.author | Acikbas, Ibrahim | - |
dc.contributor.author | Urganci, Buket Er | - |
dc.contributor.author | Azizi, Zahra | - |
dc.date.accessioned | 2025-04-25T19:11:13Z | - |
dc.date.available | 2025-04-25T19:11:13Z | - |
dc.date.issued | 2025 | - |
dc.identifier.issn | 0378-1119 | - |
dc.identifier.issn | 1879-0038 | - |
dc.identifier.uri | https://doi.org/10.1016/j.gene.2025.149379 | - |
dc.identifier.uri | https://hdl.handle.net/11499/60045 | - |
dc.description.abstract | Breast cancer, which is the most common cancer among women in T & uuml;rkiye and throughout the world, is also one of the leading causes of cancer-related deaths. A significant factor in these deaths is metastatic breast cancer, which spreads to distant organs. The metastasis of the breast tumor follows a series of steps. Many proteins and signal molecules are in charge of these processes. In addition, NEAT1, a long noncoding RNA (lncRNA), was reported to play a key role in breast cancer cell proliferation and survival. Numerous cancer kinds were also shown to have extraordinary miR-410-3p expression levels. NEAT1 and miR-410-3p expression patterns in MCF7 and MCF-10A cell lines were investigated using quantitative real-time polymerase chain reaction (qRT-PCR) in this study. The results demonstrated that NEAT1 was elevated by 2.30-fold in cancer cells in comparison to normal cells, whereas miR-410-3p was diminished by -2.85-fold. Furthermore, the transwell invasion experiment demonstrated the invasive potential of the MCF-7 cell line, whereas the MCF-10A cells could not invade. The target analysis revealed that functions of the targets were associated with biological adhesion and cel growth. In conclusion, a correlation was found between overexpression of NEAT1 and increased invasiveness of target cells, as well as inhibition of miR-410-3p, which is a regulatory target of NEAT1. | en_US |
dc.description.sponsorship | Pamukkale University Scientific Research Projects Coordination Unit [2020SABE028] | en_US |
dc.description.sponsorship | This study was supported by Pamukkale University Scientific Research Projects Coordination Unit through project numbers 2020SABE028. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Breast Cancer | en_US |
dc.subject | Invasion | en_US |
dc.subject | Metastasis | en_US |
dc.subject | Neat1 | en_US |
dc.subject | Mir-410-3P | en_US |
dc.title | The Role of the Neat1/Mir410-3p Axis in the Invasion of Breast Cancer Cells | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 951 | en_US |
dc.department | Pamukkale University | en_US |
dc.identifier.doi | 10.1016/j.gene.2025.149379 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.authorscopusid | 58875578500 | - |
dc.authorscopusid | 6507893937 | - |
dc.authorscopusid | 58703632600 | - |
dc.authorscopusid | 59112592100 | - |
dc.authorwosid | Urganci, Buket/V-6436-2019 | - |
dc.identifier.pmid | 40037420 | - |
dc.identifier.scopus | 2-s2.0-86000651965 | - |
dc.identifier.wos | WOS:001446319600001 | - |
dc.identifier.scopusquality | Q2 | - |
dc.description.woscitationindex | Science Citation Index Expanded | - |
dc.identifier.wosquality | Q2 | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.openairetype | Article | - |
item.languageiso639-1 | en | - |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.